TY - JOUR
T1 - Effect of nitrogen dioxide exposure on susceptibility to influenza A virus infection in healthy adults
AU - Goings, S. A.J.
AU - Kulle, T. J.
AU - Bascom, Rebecca
AU - Sauder, L. R.
AU - Green, D. J.
AU - Hebel, R.
AU - Clements, M. L.
PY - 1989
Y1 - 1989
N2 - The effect of NO2 exposure and human susceptibility to respiratory virus infection was investigated in a placebo-controlled, randomized, double-blind trial conducted in an environmentally controlled research chamber over 3 yr. Healthy, nonsmoking, young adult volunteers who were seronegative to influenza A/Korea/82 (H3N2) virus were randomly assigned to breathe either filtered clean air (control group) or NO2 for 2h/day for 3 consecutive days. The NO2 concentrations were 2 ppm (Year 1), 3 ppm (Year 2), and 1 or 2 ppm (Year 3). Live, attenuated cold-adapted (ca) influenza A/Korea/82 reassortant virus was administered intranasally to all subjects immediately after the second exposure. Only one of the 152 volunteers had any symptoms; this person had a low grade fever. Pulmonary function measurements and nonspecific airway reactivity to metacholine were unchanged after NO2 exposure, virus infection, or both. Infection was determined by virus recovery, a fourfold or greater increase in serum or nasal wash influenza-specific antibody titers, or both. The infection rates of the groups were 12/21 (2 ppm NO2) versus 15/23 (clean air) in Year 1, 17/22 (3 ppm NO2) versus 15/21 (clean air) in Year 2, and 20/22 (2 ppm) and 20/22 (1 ppm) versus 15/21 (clean air) in Year 3. Each group exposed to 1 or 2 ppm NO2 in the last year became infected more often (91%) than did the control group (71%), but the differences were not statistically significant. The frequencies of infection in two of the four groups exposed to NO2 were higher than the 56 to 73% infection rates observed in previous studies in healthy adult volunteers with the same dose of ca influenza A viruses. Our findings suggest, but do not prove, that NO2 alone may play a role in increasing the susceptibility of adults to respiratory virus infections.
AB - The effect of NO2 exposure and human susceptibility to respiratory virus infection was investigated in a placebo-controlled, randomized, double-blind trial conducted in an environmentally controlled research chamber over 3 yr. Healthy, nonsmoking, young adult volunteers who were seronegative to influenza A/Korea/82 (H3N2) virus were randomly assigned to breathe either filtered clean air (control group) or NO2 for 2h/day for 3 consecutive days. The NO2 concentrations were 2 ppm (Year 1), 3 ppm (Year 2), and 1 or 2 ppm (Year 3). Live, attenuated cold-adapted (ca) influenza A/Korea/82 reassortant virus was administered intranasally to all subjects immediately after the second exposure. Only one of the 152 volunteers had any symptoms; this person had a low grade fever. Pulmonary function measurements and nonspecific airway reactivity to metacholine were unchanged after NO2 exposure, virus infection, or both. Infection was determined by virus recovery, a fourfold or greater increase in serum or nasal wash influenza-specific antibody titers, or both. The infection rates of the groups were 12/21 (2 ppm NO2) versus 15/23 (clean air) in Year 1, 17/22 (3 ppm NO2) versus 15/21 (clean air) in Year 2, and 20/22 (2 ppm) and 20/22 (1 ppm) versus 15/21 (clean air) in Year 3. Each group exposed to 1 or 2 ppm NO2 in the last year became infected more often (91%) than did the control group (71%), but the differences were not statistically significant. The frequencies of infection in two of the four groups exposed to NO2 were higher than the 56 to 73% infection rates observed in previous studies in healthy adult volunteers with the same dose of ca influenza A viruses. Our findings suggest, but do not prove, that NO2 alone may play a role in increasing the susceptibility of adults to respiratory virus infections.
UR - http://www.scopus.com/inward/record.url?scp=0024345709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024345709&partnerID=8YFLogxK
U2 - 10.1164/ajrccm/139.5.1075
DO - 10.1164/ajrccm/139.5.1075
M3 - Article
C2 - 2712434
AN - SCOPUS:0024345709
SN - 1073-449X
VL - 139
SP - 1075
EP - 1081
JO - American Review of Respiratory Disease
JF - American Review of Respiratory Disease
IS - 5
ER -